Article
Factors and Outcomes of Decision Making for Cancer Clinical Trial Participation
Purpose/Objectives: To describe factors and outcomes related to the decision-making process regarding participation in a cancer clinical trial.
Design: Cross-sectional, descriptive.
Setting: Urban, academic, National Cancer Institute-designated comprehensive cancer center in the mid-Atlantic United States.
Sample: 197 patients with advanced gastrointestinal cancer.
Methods: Mailed survey using one investigator-developed instrument, eight instruments used in published research, and a medical record review.
Main Research Variables: Independent variables: disease context, sociodemographics, hope, quality of life, trust in healthcare system, trust in health professional, preference for research decision control, understanding risks, and information. Dependent variables: decision to accept or decline research participation and satisfaction with this decision.
Findings: All of the factors within the Research Decision Making Model together predicted cancer clinical trial participation and satisfaction with this decision. The most frequently preferred decision-making style for research participation was shared (collaborative) (83%).
Conclusions: Multiple factors affect decision making for cancer clinical trial participation and satisfaction with this decision. Shared decision making previously was an unrecognized factor and requires further investigation.
Implications for Nursing: Enhancing the process of research decision making may facilitate an increase in cancer clinical trial enrollment rates. Oncology nurses have unique opportunities as educators and researchers to support shared decision making by those who prefer this method for deciding whether to accept or decline cancer clinical trial participation.
Jump to a section
References
American Cancer Society. (2011). Cancer facts and figures 2011. Atlanta, GA: Author.
Avis, N. E., Smith, K. W., Link, C. L., Hortobagyi, G. N., & Rivera, E. (2006). Factors associated with participation in breast cancer treatment clinical trials. Journal of Clinical Oncology, 24, 1860-1867.
Beauchamp, T. L., & Childress, J. F. (2001). Principles of biomedical ethics(5th ed.). New York, NY: Oxford University Press.
Biedrzycki, B. A. (2010). Decision making for cancer clinical trial participation: A systematic review [Online exclusive]. Oncology Nursing Forum, 37, E387-E399. http://dx.doi.org/10.1188/10.ONF.E387-E399
Bowling, A., & Ebrahim, S. (2001). Measuring patients' preferences for treatment and perceptions of risk. Quality in Health Care, 10(Suppl. 1), i2-i8. http://dx.doi.org/10.1136/qhc.0100002
Cassileth, B. R., Zupkis, R. V., Sutton-Smith, K., & March, V. (1980). Information and participation preferences among cancer patients. Annals of Internal Medicine, 92, 832-836.
Clark, J. A., Wray, N. P., & Ashton, C. M. (2001). Living with treatment decisions: Regrets and quality of life among men treated for metastatic prostate cancer. Journal of Clinical Oncology, 19, 72-80.
Cohen, M. Z., Slomka, J., Pentz, R. D., Flamm, A. L., Gold, D., Herbst, R. S., & Abbruzzese, J. L. (2007). Phase I participants' views of quality of life and trial participation burdens. Supportive Care in Cancer, 15, 885-890.
Cox, K., & Avis, M. (1996). Psychosocial aspects of participation in early anticancer drug trials: Report of a pilot study. Cancer Nursing, 19, 177-186. http://dx.doi.org/10.1097/00002820-199606000-00004
Cupples, S., Nolan, M. T., Augustine, S., & Kynock, D. (1998). Perceived stressors and coping strategies among heart transplant candidates. Journal of Transplant Coordination, 8, 179-187.
Daughtery, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., & Siegler, M. (1995). Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology, 13, 1062-1072. http://dx.doi.org/10.1002/pon.829
Daugherty, C. K., Fitchett, G., Murphy, P. E., Peterman, A. H., Banik, D. M., Hlubocky, F., & Tartaro, J. (2005). Trusting God and medicine: Spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psycho-Oncology, 14, 135-146.
Degner, L. F., & Beaton, J. I. (1987). Life-death decisions in health care. Washington, DC: Hemisphere Publishing.
Degner, L. F., & Sloan, J. A. (1992). Decision making during serious illness: What role do patients really want to play? Journal of Clinical Epidemiology, 45, 941-950. http://dx.doi.org/10.1016/0895-4356(92)90110-9
Dillman, D. A. (2000). Mail and Internet surveys: The tailored design method(2nd ed.). New York, NY: Johns Wiley and Sons.
Ebright, P. R., & Lyon, B. L. (2002). Understanding hope and factors that enhance hope in women with breast cancer. Oncology Nursing Forum, 29, 561-568. http://dx.doi.org/10.1188/02.ONF.561-568
Ellis, P. M., Butow, P. N., & Tattersall, M. H. (2002). Informing breast cancer patients about clinical trials: A randomized clinical trial of an educational booklet. Annals of Oncology, 13, 1414-1423.
Ferrell, B. R., Hassey-Dow, K., & Grant, M. (1995). Measurement of the quality of life in cancer survivors. Quality of Life Research, 4, 523-531.
Ferrell, B. R., Hassey-Dow, K., Leigh, S., Ly, J., & Gulasekaram, P. (1995). Quality of life in long-term cancer survivors. Oncology Nursing Forum, 22, 915-922.
Flory, J., & Emanuel, E. (2004). Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA, 292, 1593-1601. http://dx.doi.org/10.1001/jama.292.13.1593
Flynn, K. E., Weinfurt, K. P., Seils, D. M., Lin, L., Burnett, C. B., Schulman, K. A., & Meropol, N. J. (2008). Decisional conflict among patients who accept or decline participation in phase I oncology studies. Journal of Empirical Research on Human Research Ethics, 3(3), 69-77.
Gaskin, D. J., Weinfurt, K. P., Castel, L. D., DePuy, V., Li, Y., Balshem, A., … Schulman, K. A. (2004). An exploration of relative health stock in advanced cancer patients. Medical Decision Making, 24, 614-624.
Hack, T. F., Degner, L. F., Watson, P., & Sinha, L. (2006). Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psycho-Oncology, 15, 9-19.
Hack, T. F., Pickles, T., Ruether, J. D., Weir, L., Bultz, B. D., Mackey, J., & Degner, L. (2010). Predictors of distress and quality of life in patients undergoing chemotherapy. Psycho-Oncology, 19, 606-616.
Herth, K. A. (1991). Development and refinement of an instrument to measure hope. Scholarly Inquiry for Nursing Practice, 5, 39-51.
Herth, K. A. (1992). Abbreviated instrument to measure hope: Development and psychometric evaluation. Journal of Advanced Nursing, 17, 1251-1259.
Hlubocky, F. J., Ratain, M. J., Wen. M., & Daugherty, C. K. (2007). Complementary and alternative medicine among cancer patients enrolled on phase I trials: A study of prognosis, quality of life, and preferences for decision making. Journal of Clinical Oncology, 25, 548-554.
Horstmann, E., McCabe, M. S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, … Grady, C. (2005). Risks and benefits of phase 1 oncology trials, 1991 through 2002. New England Journal of Medicine, 352, 895-904. http://dx.doi.org/10.1056/NEJMsa042220
Institute of Medicine. (2002). Responsible research: A systems approach to protecting research participants. Washington, DC: National Academies Press.
Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001). Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet, 358, 1772-1777. http://dx.doi.org/10.1016/S0140-6736(01)06805-2
Kao, A. C., Green, D. C., Zaslavsky, A. M., Koplan, J. P., & Cleary, P. D. (1998). The relationship between method of physician payment and patient trust. JAMA, 280, 1708-1714.
Kass, N., Sugarman, J., Faden, R., & Schoch-Spana, M. (1996). Trust: The fragile foundation of contemporary biomedical research. Hastings Center Report, 26, 25-29.
Kutner, J. S., Vu, K. O., Prindiville, S. A., & Byers, T. E. (2000). Patient age and cancer treatment decisions. Cancer Practice, 8, 114-119.
Little, R. J., & Rubin, D. B. (1987). Statistical analysis with missing data. New York, NY: Wiley.
McCorkle, R., Cooley, M. E., & Shea, J. A. (2000). A user's manual for the Symptom Distress Scale. Retrieved from http://fhsson.mcmaster.ca/apn/images/stories/pdfs/Symptom_Distress_Scale_user_manual.pdf
McCorkle, R., & Young, K. (1978). Development of a symptom distress scale. Cancer Nursing, 1, 373-378.
Miller, F. G., & Joffe, S. (2009). Benefit in phase 1 oncology trials: Therapeutic misconception or reasonable treatment option? Clinical Trials, 5, 617-623. http://dx.doi.org/10.1177/1740774508097576
Moore, S. (2001). A need to try everything: Patient participation in phase I trials. Journal of Advanced Nursing, 33, 738-747.
Moreno, J. D. (2001). It's not about the money. American Journal of Bioethics, 1(2), 46-47. http://dx.doi.org/10.1162/152651601300169059
Motulsky, H. (2010). Intuitive biostatistics: A nonmathematical guide to statistical thinking(2nd ed.). New York, NY: Oxford University Press.
National Institutes of Health. (n.d.). Directive for human experimentation: Nuremberg Code. Retrieved from http://ohsr.od.nih.gov/guidelines/nuremberg.html
Nguyen, T. T., Somkin, C. P., Ma, Y., Fung, L. C., & Nguyen, T. (2005). Participation of Asian-American women in cancer-treatment research: A pilot study. Journal of the National Cancer Institute. Monographs, 35, 102-105. http://dx.doi.org/10.1093/jncimonographs/lgi046
Nolan, M. T., Cupples, S. A., Brown, M., Pierce, L., Lepley, D., & Ohler, L. (1992). Perceived stress and coping strategies among families of cardiac transplant candidates during the organ waiting period. Heart and Lung, 21, 540-547.
Nolan, M. T., Hughes, M., Narendra, D. P., Sood, J. R., Terry, P.B, Astrow, A. B., … Sulmasy, D. P. (2005). When patients lack capacity: The roles that patients with terminal diagnoses would choose for their physicians and loved ones in making medical decisions. Journal of Pain and Symptom Management, 30, 342-353.
O'Connor, A. M. (1995). Validation of a decisional conflict scale. Medical Decision Making, 15, 25-30.
Office for Human Research Protections. (1993). Institutional review board guidebook. Retrieved from http://www.hhs.gov/ohrp/archive/irb/irb_guidebook.htm
Rose, A., Peters, N., Shea, J. A., & Armstrong, K. (2004). Development and testing of the health care system distrust scale. Journal of General Internal Medicine, 19, 57-63. http://dx.doi.org/10.1111/j.1525-1497.2004.21146.x
SPSS Inc. (2009). PASW® Missing Values 18. Chicago, IL: Author.
Stevens, T., & Ahmedzai, S. H. (2004). Why do breast cancer patients decline entry into randomized trials and how do they feel about their decision later: A prospective, longitudinal, in-depth interview study. Patient Education and Counseling, 52, 341-348.
Sulmasy, D. P., Hughes, M. T., Thompson, R. E., Astrow, A. B., Terry, P. B., Kub, J., & Nolan, M. T. (2007). How would terminally ill patients have others make decisions for them in the event of decisional incapacity? A longitudinal study. Journal of the American Geriatrics Society, 55, 1981-1988. http://dx.doi.org/10.1111/j.1532-5415.2007.01473.x
Thorndike, R. M., & Dinnel, D. L. (2000). Basic statistics for the behavioral sciences. Upper Saddle River, NJ: Pearson Education.
Todd, A. M., Laird, B. J., Boyle, D., Boyd, A. C., Colvin, L. A., & Fallon, N. T. (2009). A systematic review examining the literature on attitudes of patients with advanced cancer toward research. Journal of Pain and Symptom Management, 37, 1078-1085.
Wonghongkul, T., Moore, S. M., Musil, C., Schneider, S., & Deimling, G. (2000). The influence of uncertainty in illness, stress appraisal, and hope on coping in survivors of breast cancer. Cancer Nursing, 23, 422-429. http://dx.doi.org/10.1097/00002820-200012000-00004
World Medical Association. (2008). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Retrieved from http://www.wma.net/en/30publications/10policies/b3/index.html